Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
NGNE

Neurogene (NGNE) stock: insider trades, news & valuation

Heavy selling
Close · Oct 9, 2026 $26.40 -0.4% on the day -16.3% over 12 months 52-week range $16.37 – $42.84

Share price and insider trades

NGNE closeInsider buyInsider sale
1020304050NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $21,612 on 2026-07-06 · Christine Mikail CvijicSold $25,170 on 2026-07-01 · Christine Mikail CvijicSold $120,528 on 2026-02-27 · Christine Mikail CvijicSold $141,424 on 2026-07-02 · Christine Mikail CvijicSold $147,408 on 2026-03-26 · Christine Mikail Cvijic, Julie Jordan, Rachel McminnSold $151,746 on 2026-07-07 · Christine Mikail CvijicSold $225,623 on 2026-03-13 · Christine Mikail Cvijic, Stuart CobbSold $300,048 on 2026-05-06 · Christine Mikail Cvijic
Bought, 12 months$0
Sold, 12 months$1.1M
Insiders buying0
Insiders selling4

Neurogene insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 4 sold $1.1M of NGNE stock on the open market.

NGNE insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q1 2026: $494K sold (10 trades)Q1 2026Q2 2026: $300K sold (2 trades)Q2 2026Q3 2026: $340K sold (5 trades)Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0$340K5
Q2 2026—0$300K2
Q1 2026—0$494K10

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day1.1×Last 5 sessions
Insiders' paper profit—On all tracked purchases —

Summary

Over the past 12 months, 0 Neurogene Inc. insiders reported open-market purchases totaling $0, while 4 insiders reported sales totaling $1.1M. 17 of 17 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Jul 7SEC Christine Mikail CvijicCFO, President Sell Plan 4,20084,040 held (−5%) $36.13 $152K -26.9% —
Jul 7SEC Christine Mikail CvijicCFO, President Sell Plan 60088,240 held (−1%) $36.02 $22K -26.7% —
Jul 2SEC Christine Mikail CvijicCFO, President Sell Plan 2,53190,370 held (−3%) $34.58 $88K -23.7% —
Jul 2SEC Christine Mikail CvijicCFO, President Sell Plan 1,53088,840 held (−2%) $35.23 $54K -25.1% —
Jul 2SEC Christine Mikail CvijicCFO, President Sell Plan 73992,901 held (−1%) $34.06 $25K -22.5% —
May 8SEC Christine Mikail CvijicCFO, President Sell Plan 4,80093,640 held (−5%) $32.44 $156K -18.6% —
May 8SEC Christine Mikail CvijicCFO, President Sell Plan 4,80098,440 held (−5%) $30.07 $144K -12.2% —
Mar 30SEC Rachel McminnCEO Sell Plan 3,3521,344,307 held (−0%) $22.07 $74K +19.6% —
Mar 30SEC Christine Mikail CvijicCFO, President Sell Plan 2,558103,240 held (−2%) $21.62 $55K +22.1% —
Mar 30SEC Julie JordanChief Medical Officer Sell Plan 82812,472 held (−6%) $21.89 $18K +20.6% —
Mar 17SEC Stuart CobbChief Scientific Officer Sell Plan 3,99133,303 held (−11%) $20.41 $81K +29.3% —
Mar 17SEC Stuart CobbChief Scientific Officer Sell Plan 2,65830,645 held (−8%) $21.34 $57K +23.7% —
Mar 17SEC Christine Mikail CvijicCFO, President Sell Plan 2,387107,456 held (−2%) $20.42 $49K +29.3% —
Mar 17SEC Christine Mikail CvijicCFO, President Sell Plan 1,395106,061 held (−1%) $21.25 $30K +24.2% —
Mar 17SEC Christine Mikail CvijicCFO, President Sell Plan 263105,798 held (−0%) $22.02 $6K +19.9% —
Mar 17SEC Stuart CobbChief Scientific Officer Sell Plan 14830,497 held (−0%) $22.08 $3K +19.6% —
Mar 3SEC Christine Mikail CvijicCFO, President Sell Plan 4,800109,843 held (−4%) $25.11 $121K +5.1% —

Insiders at Neurogene Inc.

InsiderBoughtSoldLast filingScore
Christine Mikail CvijicCFO, President — $900K Jul 7, 2026 —
Stuart CobbChief Scientific Officer — $141K Mar 17, 2026 —
Rachel McminnCEO — $74K Mar 30, 2026 —
Julie JordanChief Medical Officer — $18K Mar 30, 2026 —

NGNE stock: common questions

Are Neurogene Inc. insiders buying NGNE stock?

In the past 12 months, 0 insiders reported open-market purchases of NGNE worth $0.

Are Neurogene Inc. insiders selling NGNE stock?

4 insiders reported sales worth $1.1M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is NGNE's 52-week range?

Over the past year NGNE has traded between $16.37 and $42.84. It last closed at $26.40 on Oct 9, 2026.